Welcome to our dedicated page for Silvaco Group SEC filings (Ticker: SVCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Silvaco Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Silvaco Group's regulatory disclosures and financial reporting.
Silvaco Group reported mixed fourth quarter and full-year 2025 results as it pursues a turnaround strategy. Q4 2025 revenue was $18.3 million, up 2% year over year, with strong SIP growth to $5.1 million (up 483%) offset by a 31% decline in TCAD revenue to $8.8 million. Q4 GAAP net loss was $7.2 million versus $4.2 million net income a year earlier, while non-GAAP net loss was $0.8 million compared with $4.0 million non-GAAP net income.
For 2025, revenue grew 6% to $63.1 million, driven by 60% EDA growth and 98% SIP growth, but GAAP net loss widened slightly to $41.2 million and non-GAAP swung to an $11.1 million loss from $5.5 million income. Management highlighted acquisitions, a cost reduction program targeting $20 million in annualized non-GAAP operating expense savings (with $14 million executed by year-end), and guidance for Q1 2026 revenue and bookings of $15–$19 million, non-GAAP gross margin around 85%, and non-GAAP operating expenses of $14.5–$16.5 million.
RHINES WALDEN C reported acquisition or exercise transactions in this Form 4 filing.
Silvaco Group, Inc. director and Chief Executive Officer Walden C. Rhines received an equity grant in the form of 28,170 shares of common stock on February 21, 2026 at a stated price of $0.00 per share, increasing his directly held common stock to 134,088 shares after the award.
According to the accompanying disclosure, the grant represents restricted stock units (RSUs) issued under an employment agreement effective August 19, 2025, with each RSU convertible into one share of common stock. These RSUs are scheduled to vest on March 31, 2027, with vesting accelerating if Silvaco terminates his employment for any reason or if he resigns after an uncured material breach of the agreement by the company before that vesting date.
Jackson Candace reported acquisition or exercise transactions in this Form 4 filing.
Silvaco Group, Inc. reported that officer Candace Jackson received a grant of 15,000 shares of common stock in the form of restricted stock units. The RSUs were granted on March 2, 2026, with vesting beginning January 1, 2026. One-sixteenth of the RSUs vest each quarter until they are fully vested on January 1, 2030. After this award, Jackson directly owns 56,666 shares of Silvaco common stock.
Silvaco Group, Inc. reported an equity compensation grant to its Chief Financial Officer, Christopher John Zegarelli. He acquired 100,000 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Silvaco common stock at no purchase price.
The RSUs were granted on March 2, 2026, with vesting starting January 1, 2026. One-sixteenth of the award vests each quarter until fully vested on January 1, 2030. Following this grant, Zegarelli holds 539,407 shares of common stock directly.
Silvaco Group, Inc. updated its corporate governance by adopting Amended and Restated Bylaws, effective February 13, 2026. The board of directors approved these changes to align the stockholder approval threshold required for removing directors with the threshold already set out in the company’s Amended and Restated Certificate of Incorporation.
The detailed terms of the new bylaws are contained in the Amended and Restated Bylaws filed as Exhibit 3.2, which are incorporated by reference. This change focuses on consistency between the company’s core governing documents rather than altering its business operations or financial position.
Silvaco Group, Inc. filed a prospectus supplement covering the offer and sale of 167,281 shares of its common stock to John Cary, a former equityholder of Tech-X Corporation. These shares are being issued as part of the consideration for Silvaco’s acquisition of Tech-X.
The stock issuance satisfies contingent earnout obligations tied to developmental milestones and a portion of additional purchase consideration from post-closing adjustments, in each case in lieu of cash. The shares are offered under Silvaco’s effective Form S-3 shelf registration statement, and the company will not receive any cash proceeds from this issuance.
Silvaco Group, Inc. is issuing 167,281 shares of common stock to John Cary as part of the consideration for its acquisition of Tech-X Corporation. The shares satisfy contingent earnout milestones and post-closing purchase price adjustments in lieu of cash payments.
The company will not receive cash proceeds from this primary issuance, which is made directly without underwriters. For dilution illustration, Silvaco uses an effective offering price of $3.83 per share and reports historical net tangible book value of $1.70 per share as of September 30, 2025 based on 30,531,193 shares outstanding.
Silvaco Group, Inc. reported an insider share purchase by one of its directors. On December 11, 2025, the director bought 1,000 shares of common stock at $4.23 per share, coded as a purchase in the filing.
After this transaction, the director beneficially owns 91,777 shares of Silvaco Group common stock, held directly. The filing’s transaction tables show activity only in non-derivative common stock, with no derivative securities listed.
Silvaco Group, Inc. is undertaking a targeted Restructuring program started in October 2025 to streamline its organizational structure, improve execution, and enhance stockholder value. As part of this effort, the company announced an initial involuntary reduction in force in the United States on November 24, 2025, alongside a voluntary early retirement program, a voluntary exit program, further planned involuntary reductions, and certain site closures.
Silvaco currently estimates it will record pre-tax GAAP charges ranging from $2 million to $5 million, primarily for severance, one-time termination benefits, and costs related to site closures under its global site strategy. The majority of affected employees are expected to be terminated by December 31, 2025, with the Restructuring expected to be substantially completed in fiscal year 2026, subject to various execution risks and uncertainties.